Pharmaceutical Technology on MSN
Mabwell and Aditum launch Kalexo Bio for siRNA therapy development
China’s Mabwell Bioscience and US-based Aditum Bio have launched Kalexo Bio, a new company, to develop a new small ...
REDWOOD CITY, Calif., Oct. 24, 2024 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, today announced ...
Argo Biopharmaceutical Co., Ltd. (Argo Biopharma), a clinical-stage small interfering RNA (siRNA) therapeutics company, today announced that the National Medical Products Administration of China (NMPA ...
SAN DIEGO & SHANGHAI--(BUSINESS WIRE)--Sirius Therapeutics today announced that preliminary data from its Phase 1 clinical trial of SRSD107, a next generation siRNA therapeutic under clinical ...
Codexis, Inc. recently presented data at the TIDES USA annual meeting, showcasing their ECO Synthesis platform's effectiveness in manufacturing siRNA therapeutics. Their findings emphasized reduced ...
Zacks Investment Research on MSN
NVS Inks a Licensing Deal With Arrowhead for siRNA Therapy
Novartis (NVS) has entered into a licensing and collaboration agreement with Arrowhead Pharmaceuticals, Inc. (ARWR) for the latter’s ARO-SNCA. ARO-SNCA is Arrowhead’s preclinical stage siRNA therapy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback